Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy.
about
Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancerFactors affecting tumor recurrence after curative surgery for NSCLC: impacts of lymphovascular invasion on early tumor recurrenceFluorodeoxyglucose positron emission tomography and chemotherapy-related tumor marker expression in non-small cell lung cancer.eComment. Video-assisted thoracoscopic surgery may be an alternative diagnosis and treatment option.Exploration of optimal time for initiating adjuvant chemotherapy after surgical resection: A retrospective study in Chinese patients with stage IIIA non-small cell lung cancer in a single centerRelationship between EGFR gene mutation and local metastasis of resectable lung adenocarcinomaModified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) Patients.Survival significance of epidermal growth factor receptor tyrosine kinase inhibitors and current staging system for survival after recurrence in patients with completely resected lung adenocarcinoma.Body mass index, C-reactive protein and survival in smokers undergoing lobectomy for lung cancer†.Current outcomes of postrecurrence survival in patients after resection of non-small cell lung cancer.Editorial on "Long-term survival outcome after postoperative recurrence of non-small cell lung cancer: who is 'cured' from postoperative recurrence?"The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor.Prognostic value of and in resected non-small cell lung cancer: a systematic review and meta-analysis
P2860
Q27011293-23020121-43B8-47BB-93FD-BD750A937BE9Q34430555-63DCBE00-146A-4AD1-838B-28E904B4E8DAQ35044346-4A506040-BC5E-4236-8003-6DD2DCFE59B7Q36599810-715A2837-60D2-478E-B949-6A2A90143743Q37060376-1EF247D0-F91B-4568-8E54-10764CC4BDD4Q37679095-382D3F2D-D4FA-4B73-A2B7-44031FA32596Q38642286-D4704868-32CB-48DC-A6DB-EB6968F4F751Q41522621-A8AB15CB-DB1B-437B-9E56-A45C75F7B8D6Q51136992-D68D10B6-AB18-4F5B-9F00-C75B4A2D3D14Q52715754-843A0F77-7C3B-4A3E-893C-4DD77A7E7EB7Q52806184-05CF461E-58EA-4DF9-BBE0-05F3CEBD5184Q54313517-161B7279-5791-4EBF-A0AB-62C59E707049Q58754535-4A32E660-6004-4BAB-BAFF-80750C5E3096
P2860
Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Post-recurrence survival of pa ...... duction/adjuvant chemotherapy.
@ast
Post-recurrence survival of pa ...... duction/adjuvant chemotherapy.
@en
type
label
Post-recurrence survival of pa ...... duction/adjuvant chemotherapy.
@ast
Post-recurrence survival of pa ...... duction/adjuvant chemotherapy.
@en
prefLabel
Post-recurrence survival of pa ...... duction/adjuvant chemotherapy.
@ast
Post-recurrence survival of pa ...... duction/adjuvant chemotherapy.
@en
P2093
P2860
P356
P1476
Post-recurrence survival of pa ...... duction/adjuvant chemotherapy.
@en
P2093
Katsuhiko Shimizu
Koichiro Yasuda
Masao Nakata
Riki Okita
Shinsuke Saisho
Takuro Yukawa
Yuji Hirami
P2860
P304
P356
10.1093/ICVTS/IVS450
P577
2012-11-09T00:00:00Z